PRO-LIANCE GLOBAL SOLUTIONS Joins the EASYGEN Consortium to Bring CAR-T Therapy Closer to Patients
Today, CAR-T therapy stands as one of the most groundbreaking advances in cancer treatment. However, fewer than 20% of eligible patients currently receive this life-saving therapy—primarily due to the centralized, complex, and time-consuming nature of its manufacturing process. This needs to change. We are proud to announce that PRO-LIANCE GLOBAL SOLUTIONS has joined the newly […]